The Unfinished Science of Boxed Drug Warnings - Top-Institutions - MDSpire

The Unfinished Science of Boxed Drug Warnings

  • By

  • John G. Rizk

  • John C. Lewin

  • May 22, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pharmacology
    • Drug Safety
    • Pharmacoepidemiology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Pharmacology
    • Drug Safety
    • Regulatory Policy

  • #3

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Pharmacology
    • Clinical Research

  • #4

    American College of Obstetricians and Gynecologists
    American College of Obstetricians and Gynecologists

    Washington, District of Columbia

    Key Differentiators

    • Obstetrics
    • Gynecology
    • Pharmacology

  • #5

    European Medicines Agency
    European Medicines Agency

    Amsterdam, Netherlands

    Key Differentiators

    • Regulatory Affairs
    • Pharmacology

Original Source(s)

The Unfinished Science of Boxed Drug Warnings

  • by John G. Rizk, John C. Lewin

  • May 22, 2026

Related Content

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report

Case Report: Atypical pediatric allergic bronchopulmonary aspergillosis masquerading as recurrent pneumonia